216 related articles for article (PubMed ID: 28185878)
21. A novel GLP-1/GIP dual agonist is more effective than liraglutide in reducing inflammation and enhancing GDNF release in the MPTP mouse model of Parkinson's disease.
Yuan Z; Li D; Feng P; Xue G; Ji C; Li G; Hölscher C
Eur J Pharmacol; 2017 Oct; 812():82-90. PubMed ID: 28666800
[TBL] [Abstract][Full Text] [Related]
22. Neuroprotective effect of metformin in MPTP-induced Parkinson's disease in mice.
Patil SP; Jain PD; Ghumatkar PJ; Tambe R; Sathaye S
Neuroscience; 2014 Sep; 277():747-54. PubMed ID: 25108167
[TBL] [Abstract][Full Text] [Related]
23. Chronic stress induced depressive-like behaviors in a classical murine model of Parkinson's disease.
Wang X; Xu J; Wang Q; Ding D; Wu L; Li Y; Wu C; Meng H
Behav Brain Res; 2021 Feb; 399():112816. PubMed ID: 32783904
[TBL] [Abstract][Full Text] [Related]
24. Ginsenoside Rg1 attenuates motor impairment and neuroinflammation in the MPTP-probenecid-induced parkinsonism mouse model by targeting α-synuclein abnormalities in the substantia nigra.
Heng Y; Zhang QS; Mu Z; Hu JF; Yuan YH; Chen NH
Toxicol Lett; 2016 Jan; 243():7-21. PubMed ID: 26723869
[TBL] [Abstract][Full Text] [Related]
25. Social enrichment attenuates nigrostriatal lesioning and reverses motor impairment in a progressive 1-methyl-2-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of Parkinson's disease.
Goldberg NR; Fields V; Pflibsen L; Salvatore MF; Meshul CK
Neurobiol Dis; 2012 Mar; 45(3):1051-67. PubMed ID: 22198503
[TBL] [Abstract][Full Text] [Related]
26. Distinct Nrf2 Signaling Mechanisms of Fumaric Acid Esters and Their Role in Neuroprotection against 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Induced Experimental Parkinson's-Like Disease.
Ahuja M; Ammal Kaidery N; Yang L; Calingasan N; Smirnova N; Gaisin A; Gaisina IN; Gazaryan I; Hushpulian DM; Kaddour-Djebbar I; Bollag WB; Morgan JC; Ratan RR; Starkov AA; Beal MF; Thomas B
J Neurosci; 2016 Jun; 36(23):6332-51. PubMed ID: 27277809
[TBL] [Abstract][Full Text] [Related]
27. Phloretin attenuates behavior deficits and neuroinflammatory response in MPTP induced Parkinson's disease in mice.
Zhang G; Yang G; Liu J
Life Sci; 2019 Sep; 232():116600. PubMed ID: 31251998
[TBL] [Abstract][Full Text] [Related]
28. MPP
Cunha MP; Pazini FL; Lieberknecht V; Budni J; Oliveira Á; Rosa JM; Mancini G; Mazzardo L; Colla AR; Leite MC; Santos ARS; Martins DF; de Bem AF; Gonçalves CAS; Farina M; Rodrigues ALS
Mol Neurobiol; 2017 Oct; 54(8):6356-6377. PubMed ID: 27722926
[TBL] [Abstract][Full Text] [Related]
29. Neuroprotective effect of fasudil on inflammation through PI3K/Akt and Wnt/β-catenin dependent pathways in a mice model of Parkinson's disease.
Zhao Y; Zhang Q; Xi J; Xiao B; Li Y; Ma C
Int J Clin Exp Pathol; 2015; 8(3):2354-64. PubMed ID: 26045742
[TBL] [Abstract][Full Text] [Related]
30. Chronic Systemic Inflammation Exacerbates Neurotoxicity in a Parkinson's Disease Model.
Ugalde-Muñiz P; Fetter-Pruneda I; Navarro L; García E; Chavarría A
Oxid Med Cell Longev; 2020; 2020():4807179. PubMed ID: 32015787
[TBL] [Abstract][Full Text] [Related]
31. Enhanced susceptibility to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity in high-fat diet-induced obesity.
Choi JY; Jang EH; Park CS; Kang JH
Free Radic Biol Med; 2005 Mar; 38(6):806-16. PubMed ID: 15721991
[TBL] [Abstract][Full Text] [Related]
32. The influence and the mechanism of docosahexaenoic acid on a mouse model of Parkinson's disease.
Ozsoy O; Seval-Celik Y; Hacioglu G; Yargicoglu P; Demir R; Agar A; Aslan M
Neurochem Int; 2011 Oct; 59(5):664-70. PubMed ID: 21736911
[TBL] [Abstract][Full Text] [Related]
33. Neuroprotective effects of a GIP analogue in the MPTP Parkinson's disease mouse model.
Li Y; Liu W; Li L; Hölscher C
Neuropharmacology; 2016 Feb; 101():255-63. PubMed ID: 26453962
[TBL] [Abstract][Full Text] [Related]
34. Nobiletin treatment improves motor and cognitive deficits seen in MPTP-induced Parkinson model mice.
Yabuki Y; Ohizumi Y; Yokosuka A; Mimaki Y; Fukunaga K
Neuroscience; 2014 Feb; 259():126-41. PubMed ID: 24316474
[TBL] [Abstract][Full Text] [Related]
35. Toxicity of MPTP on neurotransmission in three mouse models of Parkinson's disease.
Pain S; Gochard A; Bodard S; Gulhan Z; Prunier-Aesch C; Chalon S
Exp Toxicol Pathol; 2013 Jul; 65(5):689-94. PubMed ID: 23083629
[TBL] [Abstract][Full Text] [Related]
36. Glimepiride Prevents 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine Induced Dopamine Neurons Degeneration Through Attenuation of Glia Activation and Oxidative Stress in Mice.
Oduola-Akande MD; Ishola IO; Olubodun-Obadun TG; Akande AJ; Adeyemi OO
Neurotox Res; 2023 Jun; 41(3):212-223. PubMed ID: 36705862
[TBL] [Abstract][Full Text] [Related]
37. Neuroprotective effects and mechanisms of exercise in a chronic mouse model of Parkinson's disease with moderate neurodegeneration.
Lau YS; Patki G; Das-Panja K; Le WD; Ahmad SO
Eur J Neurosci; 2011 Apr; 33(7):1264-74. PubMed ID: 21375602
[TBL] [Abstract][Full Text] [Related]
38. Chronic and progressive Parkinson's disease MPTP model in adult and aged mice.
Muñoz-Manchado AB; Villadiego J; Romo-Madero S; Suárez-Luna N; Bermejo-Navas A; Rodríguez-Gómez JA; Garrido-Gil P; Labandeira-García JL; Echevarría M; López-Barneo J; Toledo-Aral JJ
J Neurochem; 2016 Jan; 136(2):373-87. PubMed ID: 26500044
[TBL] [Abstract][Full Text] [Related]
39. Modulation of brain-derived neurotrophic factor as a potential neuroprotective mechanism of action of omega-3 fatty acids in a parkinsonian animal model.
Bousquet M; Gibrat C; Saint-Pierre M; Julien C; Calon F; Cicchetti F
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Nov; 33(8):1401-8. PubMed ID: 19632286
[TBL] [Abstract][Full Text] [Related]
40. Mulberry fruit ameliorates Parkinson's-disease-related pathology by reducing α-synuclein and ubiquitin levels in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid model.
Gu PS; Moon M; Choi JG; Oh MS
J Nutr Biochem; 2017 Jan; 39():15-21. PubMed ID: 27741433
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]